US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 46.360
  • +1.520+3.39%
Close Jul 12 16:00 ET
  • 47.000
  • +0.640+1.38%
Post 18:40 ET
8.55BMarket Cap-35389P/E (TTM)

About Exact Sciences Company

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Company Profile

SymbolEXAS
Company NameExact Sciences
Listing DateJan 31, 2001
Issue Price14.00
Founded1995
CEOMr. Kevin T. Conroy
MarketNASDAQ
Employees6600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5505 Endeavor Lane
CityMadison
ProvinceWisconsin
CountryUnited States of America
Zip Code53719
Phone1-608-284-5700

Company Executives

  • Name
  • Position
  • Salary
  • Kevin T. Conroy
  • Chairman of the Board, President and Chief Executive Officer
  • 16.12M
  • Aaron Bloomer
  • Chief Financial Officer
  • --
  • Jacob Orville
  • Executive Vice President and General Manager, Screening
  • 3.67M
  • Brian Baranick
  • Executive Vice President and General Manager, Precision Oncology
  • 3.57M
  • James Herriott
  • Senior Vice President, General Counsel and Secretary
  • --
  • Sarah Condella
  • Executive Vice President, Human Resources
  • --
  • Scott D. Coward
  • Director
  • 1.47M
  • Michael J. Barber
  • Independent Director
  • --
  • Daniel Joseph Levangie
  • Independent Director
  • 408.75K
  • James E. Doyle
  • Lead Independent Director
  • 442.75K
  • Paul J. Clancy
  • Independent Director
  • 417.75K
  • Shacey Petrovic
  • Independent Director
  • 401.25K
  • Dr. Freda C. Lewis-Hall,M.D.
  • Independent Director
  • 402.75K
  • Kathleen Sebelius
  • Independent Director
  • 411.75K
  • Katherine S. Zanotti
  • Independent Director
  • 406.25K
  • Timothy John Scannell
  • Independent Director
  • 362.81K
  • Pierre Jacquet
  • Independent Director
  • 401.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg